Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 4, 1997, Pages 356-362

  Pearlman, David S ^a,f   Noonan, Michael J ^b   Tashkin, Donald P ^c   Goldstein, Marc F ^d   Hamedani, Abbas G ^e   Kellerman, Donald J ^e   Schaberg, Amy ^e  

^a PC ^*  (United States)

^b Allergy Associates Research Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Allergic Disease Associates   (United States)

^e GLAXOSMITHKLINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO; SALBUTAMOL; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ANXIETY NEUROSIS; ARTHRALGIA; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0030953465     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63196-1     Document Type: Article

References (23)

1. Overview of approaches to asthma therapy. In: Guidelines for the diagnosis and management of asthma. National Asthma Education Program expert panel report. Bethesda, Md: Department of Health and Human Services, 1991:35-43. (NIH publication no. 91-3042).
2. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-27.
3. Clark TGH. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1972;1: 1361-4.
4. Kerrebijn KF, van Ess-Zandvliet EM, Nejens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987;79:653-9.
5. Toogood JH, Jennings B, Baskerville JC. Aerosol corticosteroids. In: Weiss EB, Segal MS, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. 2nd ed. Boston: Little, Brown, 1985: 698-713.
6. Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990;141:S89-S96.
7. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84 (Suppl A):25-9.
8. Chervinsky P, van As A, Bronsky EA, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994;94:676-83.
9. Noonan M, Chervinsky P, Busse W, et al. Fluticasone propionate aerosol reduces oral prednisone requirements while it improves control of asthma and quality of life. Am J Respir Crit Care Med 1995;152:1467-73.
10. United Nations Environment Programme. Sixth Meeting of the Parties to the Montreal Protocol on substances that deplete the ozone layer. Nairobi. October 6-7, 1994:1-45.
11. De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. Am Rev Respir Dis 1989;140:910-6.
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
13. Lee ET. Statistical methods for survival data analysis. Belmont, California: Lifetime Learning Publication, 1980.
14. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst 1960;37:351.
15. Caddie J, Reid IW, Skinner C, et al. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet 1973;11:280-1.
16. Geddes DM. Inhaled corticosteroids: benefits and risks. Thorax 1992;47: 404-7.
17. Toogood HJ, Lefcoe NM, Haines DSM, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 59:298-308.
18. Dahl R, Lundback B, Malo JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-8.
19. Crescenzi KL, Wolfe J, Noonan M, et al. Standardized methacholine challenge testing to demonstrate bioequivalence of formulations of inhaled corticosteroids [Abstract]. Ann Allergy Asthma Immunol 1996;74:64.
20. Lundback B, Dahl R, De Jonghe M, et al. A comparison of fluticasone propionate when delivered by either the metered-dose inhaler or the Diskhaler inhaler in the treatment of mild-to-moderate asthma. Eur J Clin Res 1994; 5:11-9.
21. -1) administered by pressurized inhaler. Respir Med 1993; 87:609-20.
22. Leblanc P, Mink S, Keistinen T, et al. A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma. Allergy 1994;49:380-5.
23. Meades C, Churcher KM, Palmer JBD. An evaluation of the ease of handling the Diskhaler dry powder inhaler by asthmatic patients. Eur J Clin Res 1992;3:43-50.